Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 USD | -3.59% | -11.81% | -12.20% |
May. 14 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
May. 14 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.20% | 286M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.61% | 21.58B | |
-11.30% | 18.96B | |
-40.50% | 16.96B | |
-13.41% | 16.33B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos